Clinical Trial Update: Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for rESP injection in treating anemia in patients with chronic renal failure undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Failure with Hemodialysis

Drugs mentioned

• rESP injection

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Chronic Renal Failure With Hemodialysis | Phase 2 | Status: UNKNOWN